Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Hak

Showing results (11-20 of 110) with videos related to

Pageof 11
Sort By:
International Journal of Clinical Practice|April 30, 2016
Prescribing patterns, adherence and LDL-cholesterol response of type 2 diabetes patients initiating statin on low-dose versus standard-dose treatment: a descriptive studyF M de Vries, J Voorham, E Hak, et al.
Vaccine|February 17, 2006
Do recommended high-risk adults benefit from a first influenza vaccination?E Hak, E Buskens, K L Nichol, et al.
The American Journal of Medicine|November 3, 2001
Introducing a pneumococcal vaccine to an existing influenza immunization program: vaccination rates and predictors of noncomplianceW Opstelten, E Hak, T J Verheij, et al.
Family Practice|April 5, 2005
Prognostic factors for serious morbidity and mortality from community-acquired lower respiratory tract infections among the elderly in primary careE Hak, J Bont, A W Hoes, et al.
Vaccine|August 19, 2009
Modeling the effects of influenza vaccination of health care workers in hospital departmentsC van den Dool, M J M Bonten, E Hak, et al.
Nederlands Tijdschrift Voor Geneeskunde|June 17, 2008
[Influenza vaccination in the elderly: effectiveness not in doubt]E Hak, W Opstelten, I Looijmans-van den Akker, et al.
International Journal of Epidemiology|August 30, 2008
Quantifying the potential role of unmeasured confounders: the example of influenza vaccinationR H H Groenwold, A W Hoes, K L Nichol, et al.
The European Respiratory Journal|May 30, 2008
Usefulness of consecutive C-reactive protein measurements in follow-up of severe community-acquired pneumoniaA H W Bruns, J J Oosterheert, E Hak, et al.
Vaccine|October 24, 2013
RSV vaccine in development: assessing the potential cost-effectiveness in the Dutch elderly populationM J Meijboom, K B Pouwels, W Luytjes, et al.
International Journal of Cancer|February 20, 1997
Microvessel density in unknown primary tumorsH F Hillen, L E Hak, S R Joosten-Achjanie, et al.
Pageof 11

Showing results (11-20 of 110) with videos related to

Sort By:
Pageof 11
International Journal of Clinical Practice|April 30, 2016
Prescribing patterns, adherence and LDL-cholesterol response of type 2 diabetes patients initiating statin on low-dose versus standard-dose treatment: a descriptive studyF M de Vries, J Voorham, E Hak, et al.
Vaccine|February 17, 2006
Do recommended high-risk adults benefit from a first influenza vaccination?E Hak, E Buskens, K L Nichol, et al.
The American Journal of Medicine|November 3, 2001
Introducing a pneumococcal vaccine to an existing influenza immunization program: vaccination rates and predictors of noncomplianceW Opstelten, E Hak, T J Verheij, et al.
Family Practice|April 5, 2005
Prognostic factors for serious morbidity and mortality from community-acquired lower respiratory tract infections among the elderly in primary careE Hak, J Bont, A W Hoes, et al.
Vaccine|August 19, 2009
Modeling the effects of influenza vaccination of health care workers in hospital departmentsC van den Dool, M J M Bonten, E Hak, et al.
Nederlands Tijdschrift Voor Geneeskunde|June 17, 2008
[Influenza vaccination in the elderly: effectiveness not in doubt]E Hak, W Opstelten, I Looijmans-van den Akker, et al.
International Journal of Epidemiology|August 30, 2008
Quantifying the potential role of unmeasured confounders: the example of influenza vaccinationR H H Groenwold, A W Hoes, K L Nichol, et al.
The European Respiratory Journal|May 30, 2008
Usefulness of consecutive C-reactive protein measurements in follow-up of severe community-acquired pneumoniaA H W Bruns, J J Oosterheert, E Hak, et al.
Vaccine|October 24, 2013
RSV vaccine in development: assessing the potential cost-effectiveness in the Dutch elderly populationM J Meijboom, K B Pouwels, W Luytjes, et al.
International Journal of Cancer|February 20, 1997
Microvessel density in unknown primary tumorsH F Hillen, L E Hak, S R Joosten-Achjanie, et al.
Pageof 11